Skip to main content

Table 1 Characteristics of Participating Patients: Non-Injectors and Injectors

From: Drug treatment program patients' hepatitis C virus (HCV) education needs and their use of available HCV education services

 

Non-Injectors

(N = 121)

Injectors

(N = 159)

All Patients

(N = 280)

Female (%)

43.8

47.2

45.7

Hispanic (%)**

25.6

12.6

18.2

Race (%)***

   

   Black

44.6

18.9

30.0

   White

36.4

66.0

53.2

   Other

19.0

15.1

16.8

Age (mean, s.d.)**

37.7 (10.3)

41.2 (10.2)

39.7 (10.4)

High School degree or above (%)

66.1

71.7

69.3

Married/Common Law (%)**

12.4

27.0

20.7

Most frequently used drugs in the 6 months before treatment (%)

   

   Opiates***

36.8

80.9

62.0

   Cocaine or crack

60.7

58.6

59.5

   Alcohol

53.0

42.7

47.1

Primary drug used in the 6 months before treatment (%) ***

   

   Opiates

33.3

70.1

54.4

   Cocaine or crack

35.9

8.3

20.1

   Alcohol

16.2

6.4

10.6

   Other

14.5

15.3

15.0

Years since first used primary drug (mean, s.d.)**

17.5 (10.6)

21.2 (11.2)

19.6 (11.0)

Used primary drug every day in 6 mos. before treatment (%)***

70.1

86.6

79.6

In drug treatment before this time (%)***

52.1

73.6

64.3

   - Of these, times in drug tx. in the past (mean, s.d.)

3.3 (2.9)

4.3 (9.4)

4.0 (7.7)

Self reported health is poor or fair (%)***

23.3

45.3

35.8

Reports having tested HIV+ (%)

7.4

5.0

6.1

Reports having tested HCV+ (rather than HCV- or HCV unaware) (%)***

6.6

56.6

35.0

Does not have health insurance (%)

47.5

36.1

41.0

  1. ** p < .01
  2. *** p < .001